Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '2550.0048.14

Profile

Edit
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
URL https://www.tarsusrx.com
Investor Relations URL https://ir.tarsusrx.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Feb. 27, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
URL https://www.tarsusrx.com
Investor Relations URL https://ir.tarsusrx.com/
HQ State/Province California
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Feb. 27, 2025 (est.)
Last Earnings Release Nov. 13, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows